Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vical Inc (NASDAQ:VICL)

2.39
Delayed Data
As of 4:00pm ET
 -0.02 / -0.83%
Today’s Change
2.05
Today|||52-Week Range
3.27
+3.91%
Year-to-Date
No recent news for Vical Inc.

Today’s Trading

Previous close2.41
Today’s open2.40
Day’s range2.38 - 2.44
Volume23,638
Average volume (3 months)54,340
Market cap$27.5M
Dividend yield--
Data as of 4:00pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)-16.67%
Earnings growth (next 5 years)--
Revenue growth (last year)-30.64%
P/E ratioNM
Price/Sales1.59
Price/Book0.59

Competitors

 Today’s
change
Today’s
% change
EBIOEleven Biotherapeuti...0.000.00%
NVUSNovus Therapeutics I...+0.09+1.79%
ITEKInotek Pharmaceutica...+0.09+5.81%
TNXPTonix Pharmaceutical...-0.05-1.20%
Data as of 4:00pm ET, 09/25/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$14.5M
Annual profit (last year)-$9.0M
Net profit margin-61.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Operations
Keith D. Hall
Corporate headquarters
San Diego, California

Forecasts